NeuStim BBI Platform
Stroke and Spinal Cord Injury Rehabilitation (Motor/Sensory Recovery)
Pre-clinical/Early ClinicalActive
Key Facts
Indication
Stroke and Spinal Cord Injury Rehabilitation (Motor/Sensory Recovery)
Phase
Pre-clinical/Early Clinical
Status
Active
Company
About Neuvotion
Neuvotion is a private, pre-revenue biotech founded in 2018, pioneering a novel category of AI-guided brain-body interface (BBI) therapeutics for neurorehabilitation. Their core technology platform, NeuStim, integrates high-resolution neurostimulation with AI to maximize recovery of motor and sensory functions. The company is positioned to address a massive and growing outpatient rehabilitation market, backed by a seasoned leadership team with deep expertise in medical devices and neurosurgery. Initial media coverage suggests promising early clinical validation, though the technology remains in development.
View full company profile